Skip to content

Clinical evaluation of intake of collagen peptides in increasing skin moisture content

Clinical evaluation of intake of collagen peptides in increasing skin moisture content - Clinical evaluation of intake of collagen peptides in increasing skin moisture content

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030375
Enrollment
90
Registered
2017-12-13
Start date
2015-11-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Test food (1 g a day for 12 weeks) Test food (5 g a day for 12 weeks) Placebo food (12 weeks)

Sponsors

Siseido Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: A person who is a healthy person who does not fall under the following exclusion criteria and whose age at the time of consent acquisition date is from 35 years old to under 50 years old and who give written informed consent 1) Individuals who considered that they had dry skin 2) Individual who considered that they had decreased skin elasticity 3) Individuals who agreed to abstain from drinking alcohol from the day before measurement to the end of measurement 4) Individuals who agreed to participate in the study

Exclusion criteria

Exclusion criteria: 1) Individuals who habitually use medicines, collagen-containing supplement, skin supplement, or slimming aid 2) Individuals with skin abnormalities at the sites to be tested 3) Patients with food allergies 4) Individuals who had received cosmetic medical treatment at the sites to be tested 5) Individuals who had received facial treatment within 1 month before the start of the study 6) Individuals with chronic conditions such as atopic dermatitis 7) Patients receiving drug therapy as outpatients 8) Habitual smokers 9) Patients with asthma 10) Individuals taking or intending to take drugs for pollinosis 11) Pregnant woman, woman desiring to become pregnant, or lactating woman 12) Individuals who had participated in other studies within the previous 3 months 13) Subjects who are judged as unsuitable for the study by the investigator for other reason

Design outcomes

Primary

MeasureTime frame
Stratum corneum water content at 0, 4, 8, 12 weeks after the intake

Countries

Japan

Contacts

Public ContactKazunori Takashima

Inforward, Inc Ebisu Skin Research Center

takashima@inforward.co.jp03-5447-6411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026